- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02712099
TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques
April 9, 2017 updated by: Rehab Mohamed Abdelrahman, Ain Shams University
The purpose of this study is to evaluate the potential of the 3 D TUI view in diagnosis of morbidly adherent placenta in comparison to 2D grayscale, color Doppler and intraoperative findings.
Study Overview
Status
Completed
Conditions
Detailed Description
- This is a prospective study which will include 50 patients who will be selected from the outpatient and inpatient obstetric Ain Shams university maternity hospital.
All patients will undergo the following :
- History taking
- Clinical examination.
- For each patient, the whole placenta will be scanned in a systematic fashion using both 2D grayscale and 2D power Doppler ultrasound then displayed by 3D TUI to determine whether those patients suspected of having advanced invasive placentation.
Study Type
Observational
Enrollment (Actual)
50
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
- This is a prospective study which will include 50 patients who will be selected from the outpatient and inpatient obstetric Ain Shams university maternity hospital.
All patients will undergo the following :
- History taking
- Clinical examination.
- For each patient, the whole placenta will be scanned in a systematic fashion using both 2D grayscale and 2D power Doppler ultrasound then displayed by 3D TUI to determine whether those patients suspected of having advanced invasive placentation.
Description
Inclusion Criteria:
- History of previous cesarean section or hysterotomy.
- Placenta previa with its lower edge covering the scar of previous cesarean section
- From 28 wks to Full term.
Exclusion Criteria:
- Multiple pregnancies.
- Medical disorder as diabetes mellitus, hypertension.
- Obese patients. BMI > 30
- Intrauterine growth retardation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Loss of the Retro Placental Sonolucent Zone by 2D Grayscale Ultrasonography
Time Frame: 28 -36 weeks of gestation
|
2D grayscale ultrasonography criteria of placenta accreta by Loss of the retro placental sonolucent zone in placenta previa with its lower edge covering the scar of previous cesarean section
|
28 -36 weeks of gestation
|
Abnormal Placental Lacunae by 2D Grayscale Ultrasonography
Time Frame: 28 -36 weeks of gestation
|
2D grayscale ultrasonography criteria of placenta accreta by Abnormal placental lacunae in placenta previa with its lower edge covering the scar of previous cesarean section
|
28 -36 weeks of gestation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Crowded Vessels Over Peripheral Sub-placental Zone by Power Doppler Ultrasonography
Time Frame: 28 -36 weeks of gestation
|
Power Doppler ultrasonography criteria of Crowded vessels over peripheral sub-placental zone of in placenta previa with its lower edge covering the scar of previous cesarean section
|
28 -36 weeks of gestation
|
Abnormal Placental Lacunae by Power Doppler Ultrasonography
Time Frame: 28 -36 weeks of gestation
|
Power Doppler ultrasonography criteria by Abnormal placental lacunae in placenta previa with its lower edge covering the scar of previous cesarean section
|
28 -36 weeks of gestation
|
Crowded Vessels Over Peripheral Sub-placental Zone by 3D Tomographic Ultrasound Imaging (TUI)
Time Frame: 28 -36 weeks of gestation
|
the examiner can simultaneously display, on the monitor or on a hard copy, up to 24 preselected parallel cuts from a volume.
The slices can be generated either along the initial or any other reconstructed plane of the region of interest (ROI) in intervals of 0.5 - to 5 mm segments.
Slice thickness will be adjusted as necessary for each individual case.
The most informative image among the multiple images will be displayed with the use of CrossXBeam, a postprocessing tool that allows one to enhance tissue and border differentiation, leading to sharper depiction of the tissue margins
|
28 -36 weeks of gestation
|
Abnormal Placental Lacunae by 3D Tomographic Ultrasound Imaging (TUI)
Time Frame: 28 -36 weeks of gestation
|
3D tomographic ultrasound imaging (TUI) of placenta previa with its lower edge covering the scar of previous cesarean section the examiner can simultaneously display, on the monitor or on a hard copy, up to 24 preselected parallel cuts from a volume.
The slices can be generated either along the initial or any other reconstructed plane of the region of interest (ROI) in intervals of 0.5 - to 5 mm segments.
Slice thickness will be adjusted as necessary for each individual case.
The most informative image among the multiple images will be displayed with the use of CrossXBeam, a postprocessing tool that allows one to enhance tissue and border differentiation, leading to sharper depiction of the tissue margins
|
28 -36 weeks of gestation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2015
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
March 1, 2016
Study Registration Dates
First Submitted
March 9, 2016
First Submitted That Met QC Criteria
March 14, 2016
First Posted (Estimate)
March 18, 2016
Study Record Updates
Last Update Posted (Actual)
May 15, 2017
Last Update Submitted That Met QC Criteria
April 9, 2017
Last Verified
April 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TUI 3D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
TUI 3D in Diagnosis of Placenta Accreta: Comparison with Gray-scale and Color Doppler Techniques
- This is a prospective study which will include 50 patients who will be selected from the outpatient and inpatient obstetric Ain Shams university maternity hospital.
- Patient consent should be taken first.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Placenta Accreta
-
Kasr El Aini HospitalUnknownPlacenta Accreta in Placenta Previa Anterior
-
Ain Shams Maternity HospitalCompleted
-
Sohag UniversityRecruiting
-
Maternal and Child Health Hospital of FoshanWithdrawnPlacenta Accreta SpectrumChina
-
Ain Shams UniversityNot yet recruiting
-
Ain Shams UniversityUnknownPlacenta Accreta, Third TrimesterEgypt
-
HaEmek Medical Center, IsraelTechnion, Israel Institute of TechnologyUnknown
-
Necmettin Erbakan UniversityRecruitingPlacenta Accreta, Third TrimesterTurkey
-
Hatem AbuHashimCompletedPlacenta Accreta SpectrumEgypt
-
Hatem AbuHashimUnknownPlacenta Accreta Spectrum